Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Open debate: is it ever justified to withhold clinical trial data?

The debate over open access to clinical trial data is not a new one, and in August two editorials in the New England Journal of Medicine drew the battle lines once more. The big question: does it strengthen academic research, or lead investigators vulnerable to ‘data parasites’? Abi Millar looks at both sides of the argument.

Go Top